Amneal Generics Unit Continues To Grow Following Complex Products Shift

Firm Had Raised Its 2023 Guidance Ahead Of Results Publication

 
• By Chloe Kent

Amneal’s generics portfolio delivered considerable growth during Q3, as a result of its ongoing shift toward complex products and successful new launches.

Amneal sign on its headquarters building in Bridgewater, NJ
Amneal has long been shifting its focus toward complex generics • Source: Shutterstock

More from Earnings

More from Business